V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10441200 | 10033502 | 1.85 | 85 | Palliative (P) | 2017-11-08 | 2017-11-13 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE | 100273654 |
| 10441223 | 10033503 | 1.57 | 89 | Curative (C) | 2017-02-14 | 2017-03-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101682008 |
| 10441228 | 10033504 | 1.75 | 66.3 | null | 2020-11-27 | 2020-11-28 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 100561240 |
| 10441230 | 10033505 | 1.79 | 113.3 | null | 2016-11-21 | 2018-05-30 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101815792 |
| 10441255 | 10033506 | 1.67 | 0 | 03 | null | 2018-03-10 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 101546403 |
| 10441294 | 10033507 | 1.07 | null | Curative (C) | 2017-11-20 | 2017-12-09 | CAPECITABINE + OXALIPLATIN | N | N | RITUXIMAB | 101351138 |
| 10441321 | 10033508 | 0 | 89 | null | 2019-12-14 | 2019-12-14 | IBRUTINIB | 02 | null | IBRUTINIB | 100975333 |
| 10441336 | 10033509 | 1.72 | 75.5 | Curative (C) | 2018-09-16 | 2018-10-07 | Docetaxel | 02 | N | DOCETAXEL | 101132128 |
| 10441340 | 10033510 | 1.74 | 80.55 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-21 | Capecitabine | 02 | null | CAPECITABINE | 101221651 |
| 10441345 | 10033511 | 1.62 | 82.6 | 03 | 2021-08-03 | 2021-08-30 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101281242 |
| 10441359 | 10033512 | 1.61 | 78.4 | 03 | 2020-06-05 | 2020-06-26 | Capecitabine | 02 | N | CAPECITABINE | 101075801 |
| 10441365 | 10033513 | 1.6 | 105 | 03 | 2018-04-03 | 2018-04-19 | Capecitabine + Oxaliplatin 21day | 2 | N | PEMBROLIZUMAB | 101661425 |
| 10441375 | 10033514 | 1.57 | 50 | 03 | 2017-12-09 | 2018-01-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100416460 |
| 10441396 | 10033515 | 1.61 | 114.8 | Curative (C) | 2014-10-25 | 2014-11-01 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100136528 |
| 10441403 | 10033516 | null | null | Palliative (P) | 2017-10-12 | 2017-10-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100126045 |
| 10441406 | 10033517 | 1.5 | 65 | null | 2018-12-09 | 2018-12-10 | IBRUTINIB | null | null | IBRUTINIB | 100019925 |
| 10441409 | 10033518 | 1.78 | null | null | 2020-10-17 | 2020-10-29 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100491164 |
| 10441414 | 10033519 | 1.56 | null | null | 2021-12-17 | 2021-12-27 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100329163 |
| 10441424 | 10033520 | 1.75 | 77.7 | Adjuvant (A) | 2017-10-12 | 2017-10-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101314862 |
| 10441428 | 10033521 | null | 79.6 | Palliative (P) | 2016-09-24 | 2016-09-25 | Rituximab | 02 | N | RITUXIMAB | 100272833 |
| 10441439 | 10033522 | 1.71 | 71 | Palliative (P) | 2017-05-15 | 2017-05-15 | IBRUTINIB | 02 | N | IBRUTINIB | 100283385 |
| 10441455 | 10033523 | 1.83 | 84.3 | null | 2019-04-25 | 2019-05-06 | Capecitabine + Oxaliplatin 21day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100855414 |
| 10441466 | 10033524 | null | 84 | null | 2021-12-13 | 2021-12-13 | Docetaxel | 02 | null | DOCETAXEL | 101526594 |
| 10441469 | 10033525 | 1.83 | 63.8 | null | 2021-09-14 | 2021-09-17 | IBRUTINIB | 02 | null | IBRUTINIB | 100780402 |
| 10441470 | 10033526 | 1.63 | 86 | Adjuvant (A) | 2019-03-15 | 2019-03-25 | Capecitabine | 02 | null | CAPECITABINE | 100549806 |
| 10441493 | 10033527 | 1.5 | 74.9 | Neo-adjuvant (N) | 2017-01-15 | 2017-01-21 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100150367 |
| 10441504 | 10033528 | 1.71 | 77.6 | Neo-adjuvant (N) | 2016-06-26 | 2016-07-01 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100002188 |
| 10441507 | 10033529 | 1.72 | 72.3 | null | 2017-02-16 | 2019-12-23 | IBRUTINIB | 02 | null | IBRUTINIB | 101085318 |
| 10441508 | 10033530 | 1.67 | 78.4 | 03 | 2018-05-24 | 2018-06-09 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101265302 |
| 10441515 | 10033531 | 1.74 | 51.8 | Curative (C) | 2018-11-09 | 2018-11-15 | Rituximab (Maintenance) | 02 | N | RITUXIMAB | 100842714 |
| 10441536 | 10033532 | 1.77 | 96 | Palliative (P) | 2019-09-20 | 2019-09-23 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 101827956 |
| 10441548 | 10033533 | 1.8 | 73.8 | null | 2020-01-11 | 2020-02-22 | IBRUTINIB | 02 | null | IBRUTINIB | 101708715 |
| 10441556 | 10033534 | 1.77 | 62.1 | Curative (C) | 2019-05-26 | 2019-06-23 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101863412 |
| 10441577 | 10033535 | 1.76 | 71.7 | null | 2021-11-27 | 2021-11-27 | IBRUTINIB | 02 | null | IBRUTINIB | 101175136 |
| 10441591 | 10033537 | 1.75 | 69.8 | null | 2020-10-14 | 2020-10-21 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100223819 |
| 10441600 | 10033538 | 1.46 | null | 03 | 2018-06-05 | 2018-06-05 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100015470 |
| 10441601 | 10033539 | 1.54 | 62.6 | Curative (C) | 2019-02-14 | 2019-02-28 | Rituximab | 02 | N | RITUXIMAB | 101784407 |
| 10441669 | 10033540 | 1.58 | 52.2 | 03 | 2018-09-08 | 2018-09-08 | Capecitabine + Oxaliplatin 21day | N | N | PEMBROLIZUMAB | 100407484 |
| 10441686 | 10033541 | 1.69 | 76.2 | null | 2018-08-31 | 2018-10-08 | Capecitabine | 02 | null | CAPECITABINE | 100858239 |
| 10441717 | 10033542 | 1.78 | 92 | Curative (C) | 2020-12-28 | 2021-01-10 | Capecitabine | 02 | N | CAPECITABINE | 100997985 |
| 10441733 | 10033543 | null | null | null | 2018-01-18 | 2018-01-18 | Rituximab | 99 | null | RITUXIMAB | 101335490 |
| 10441749 | 10033544 | 1.87 | 85 | null | 2018-10-09 | 2018-10-14 | Capecitabine | 02 | null | CAPECITABINE | 100789992 |
| 10441755 | 10033545 | 1.71 | 80.8 | null | 2022-01-29 | 2022-02-17 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100821405 |
| 10441758 | 10033546 | 1.77 | 71 | Disease modification (D) | 2020-08-09 | 2020-08-22 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 101408880 |
| 10441795 | 10033547 | 1.73 | 53 | null | 2021-12-03 | 2021-12-03 | IBRUTINIB | 02 | null | IBRUTINIB | 100682118 |
| 10441798 | 10033548 | 1.7 | 91.5 | 03 | 2016-10-20 | 2016-11-24 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100540903 |
| 10441815 | 10033549 | 1.75 | 96.2 | Palliative (P) | 2018-01-03 | 2018-01-15 | Capecitabine | N | N | CAPECITABINE | 100745002 |
| 10441821 | 10033550 | 1.78 | 82.4 | Palliative (P) | 2016-08-07 | 2016-08-07 | IBRUTINIB | 02 | N | IBRUTINIB | 101020156 |
| 10441824 | 10033551 | 1.73 | 70 | Palliative (P) | 2016-05-05 | 2016-05-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100575476 |
| 10441833 | 10033552 | 1.7 | 73.6 | Curative (C) | 2016-07-12 | 2016-07-12 | Rituximab | 02 | N | RITUXIMAB | 101641306 |